Ypsomed is a leader in the development and manufacturing of injection and infusion systems. The company is keenly aware of the multi-billion dollar problem of poor medication adherence and the need to measure medicine intake and ensure doses are taken at the correct time.
Ypsomed sought to create a digital solution for medication adherence monitoring and smart device management for contract research organizations’ (CROs) use in clinical trials, including self-injection systems for trial participants to administer medications at home. Yet the company faced serious demands for remote device management, global scale, and privacy and security regulations such as HIPAA and GDPR.
To solve these challenges, Ypsomed adopted Philips’ HealthSuite digital platform (HSDP), a cloud platform built on Amazon Web Services (AWS). HSDP allows Ypsomed to connect devices to the cloud and remotely manage them; store data; and manage and scale services globally within healthcare regulatory, privacy, and security requirements.
Leveraging the power of the cloud, Ypsomed, Philips, and AWS can contribute to enhancing medication adherence in the clinical trials process.
Register to learn
- How to use connected self-injection devices to enhance patient adherence during clinical trials
- How to leverage device-to-cloud connectivity, IoT, and data integrations that meet healthcare regulatory, privacy, and security requirements to accelerate clinical trials
- How to create “smart” solutions using Philips HealthSuite digital platform as a managed platform to consume AWS services including Amazon EC2, Amazon S3, and AWS Lambda
Who should attend?
CIOs, CTOs, CISOs, VPs of IT, C-level or LOB managers, software development managers, system architects, product managers
Andreas Schneider, PhD - Innovation & Business Development Manager, Ypsomed
Dale Wiggins - General Manager, HealthSuite Digital Platform, Philips
Oxana Pickeral, PhD - Global Healthcare & Life Sciences Segment Leader, Amazon Web Services